West Paces Advisors’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.2K Sell
322
-77
-19% -$9.5K 0.01% 265
2026
Q2
$41K Buy
+399
New +$26K 0.01% 289
2025
Q2
– Sell
-322
Closed -$12.6K – 532
2025
Q1
$12.6K Hold
322
– – ﹤0.01% 326
2024
Q4
$15K Hold
322
– – ﹤0.01% 319
2024
Q3
$14.5K Hold
322
– – ﹤0.01% 322
2024
Q2
$15.9K Hold
322
– – ﹤0.01% 310
2024
Q1
$11K Hold
322
– – ﹤0.01% 353
2023
Q4
$11.9K Hold
322
– – ﹤0.01% 346
2023
Q3
$6.52K Hold
322
– – ﹤0.01% 375
2023
Q2
$6.59K Hold
322
– – ﹤0.01% 399
2023
Q1
$4.86K Hold
322
– – ﹤0.01% 429
2022
Q4
$7.67K Hold
322
– – ﹤0.01% 374
2022
Q3
$11.3K Hold
322
– – ﹤0.01% 337
2022
Q2
$11.3K Hold
322
– – ﹤0.01% 359
2022
Q1
$15.9K Hold
322
– – 0.01% 332
2021
Q4
$24.9K Hold
322
– – 0.01% 290
2021
Q3
$34.4K Hold
322
– – 0.01% 241
2021
Q2
$42.9K Hold
322
– – 0.02% 218
2021
Q1
$39.9K Buy
+322
New +$48.9K 0.02% 210

Other funds holding TWST

West Paces Advisors's TWST Position: Q3 2026 in Review

West Paces Advisors reduced its Twist Bioscience (TWST) stake by 19% in Q3 2026, selling an estimated $9.5K and leaving 322 shares worth $62.2K. The position accounts for 0.01% of the portfolio, ranked #265.

West Paces Advisors first reported a position in TWST in Q1 2021 and has held it in 19 quarters since. 155 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • West Paces Advisors held 322 shares of Twist Bioscience worth $62.2K as of Q3 2026.
  • West Paces Advisors sold 77 Twist Bioscience shares in Q3 2026, an estimated $9.5K.
  • Twist Bioscience made up 0.01% of West Paces Advisors's portfolio in Q3 2026, its #265 holding.
  • West Paces Advisors first reported a position in Twist Bioscience in Q1 2021 and has held it in 19 quarters since.
  • 155 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.